PSR1 COST-EFFECTIVENESS OF CLOPIDOGREL VERSUS ASPIRIN IN THE PREVENTION OF ISCHEMIC EVENTS IN STROKE AND TIA PATIENTS- A FOUR-EUROPEAN COUNTRY ANALYSIS
May 1, 2005, 00:00 AM
10.1016/S1098-3015(10)62878-1
https://www.valueinhealthjournal.com/article/S1098-3015(10)62878-1/fulltext
Section Title :
Section Order :
314
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)62878-1&doi=10.1016/S1098-3015(10)62878-1